For the year ending 2025-12-31, RDNT had $27,195K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) income | 17,047 |
| Depreciation and amortization | 152,127 |
| Non-cash lease expense | 59,867 |
| Equity in earnings of joint ventures, net of dividend | 5,803 |
| Amortization of deferred financing costs and loan discount | 3,014 |
| Loss on sale and disposal of equipment | -9,658 |
| Loss on extinguishment of debt | 0 |
| Gain on contribution of imaging centers into joint venture | 0 |
| Lease abandonment charges | -8,563 |
| Amortization of cash flow hedge | 2,273 |
| Non-cash change in fair value of interest rate swaps | -7,112 |
| Stock-based compensation | 54,601 |
| Loss on impairment | 0 |
| Change in fair value of contingent consideration | 111 |
| Accounts receivable | 9,560 |
| Other current assets | -2,279 |
| Other assets | 5,710 |
| Deferred taxes | -10,828 |
| Operating lease liability | -62,816 |
| Deferred revenue | 2,813 |
| Accounts payable, accrued expenses and other | 52,416 |
| Net cash provided by operating activities | 298,820 |
| Purchase of imaging facilities and other acquisitions, net of cash acquired | 133,422 |
| Purchase of property and equipment | 213,251 |
| Proceeds from sale of equipment | 1,288 |
| Equity contributions in joint ventures | 4,147 |
| Collection of notes receivable | 5,667 |
| Net cash used in investing activities | -343,865 |
| Principal payments on notes and leases payable | 7,025 |
| Payments on term loan debt | 20,756 |
| Proceeds from issuance of debt, net of issuance costs | 99,001 |
| Sale of noncontrolling interests | 2,389 |
| Payments of contingent consideration and holdbacks | 2,249 |
| Distributions paid to noncontrolling interests | 4,602 |
| Proceeds from issuance of common stock | 0 |
| Proceeds from issuance of common stock upon exercise of options | 5,449 |
| Net cash provided by financing activities | 72,207 |
| Effect of exchange rate changes on cash | 33 |
| Net increase in cash and cash equivalents | 27,195 |
| Cash and cash equivalents, beginning of period | 740,020 |
| Cash and cash equivalents, end of period | 767,215 |
RadNet, Inc. (RDNT)
RadNet, Inc. (RDNT)